Product Pathways - PathScan ELISA
PathScan® Phospho-NF-κB p65 (Ser536) Sandwich ELISA Kit #7173
| Kit Includes | Volume | Solution Color |
|---|---|---|
| NF-Kappa B p65 (8F8) Mouse mAb Coated Microwells | ||
| Phospho-NF-Kappa B p65 Detection Antibody | 11 milliliters | |
| Anti-rabbit IgG HRP-Linked Ab | 11 milliliters | |
| TMB Substrate | 11 milliliters | Colorless |
| STOP Solution | 11 milliliters | Colorless |
| Sealing Tape | 2 sheets | |
| 20X Wash Buffer | 25 milliliters | Colorless |
| Sample Diluent | 25 milliliters | Blue |
| Cell Lysis Buffer (10X) # 9803 | 15 milliliters | Yellowish |
Note: 12 8-well modules –Each module is designed to break apart for 8 tests.
Note: Kit should be stored at 4°C with the exception of Cell Lysis Buffer (10X), which is stored at –20°C (packaged separately).
Species Cross-Reactivity
H M
Reactivity Key: H=Human M=Mouse
Description
CST's PathScan® Phospho-NF-KappaB p65 (Ser536) Sandwich ELISA Kit is a solid phase sandwich enzyme-linked immunosorbent assay (ELISA) that detects endogenous levels of Phospho-NF-KappaB p65 protein. A NF-KappaB p65 Mouse mAb (8F8) #3028* has been coated onto the microwells. After incubation with cell lysates, both phospho- and nonphospho-NF-KappaB p65 proteins are captured by the coated antibody. Following extensive washing, Phospho-NF-KappaB p65 (Ser536) (93H1) Rabbit mAb #3033* is added to detect the captured phospho-NF-KappaB p65 protein. Anti-rabbit IgG, HRP-linked Antibody #7074* is then used to recognize the bound detection antibody. HRP substrate, TMB, is added to develop color. The magnitude of optical density for this developed color is proportional to the quantity of phospho-NF-KappaB p65 (Ser536).* Antibodies in kit are custom formulations specific to kit.
Specificity / Sensitivity
CST's PathScan® Phospho-NF-KappaB p65 (Ser536) Sandwich ELISA Kit detects endogenous levels of phospho-NF-KappaB p65 at Ser536. As shown in Figure 1, using the Phospho-NF-KappaB p65 (Ser536) ELISA Kit #7173, a significant induction of Phospho-NF-KappaB p65 (Ser536) in HeLa cells treated with TNF-alpha is detected. However, levels of NF-KappaB p65 (either untreatead or treated), detected by the Total NF-KappaB p65 Sandwich ELISA Kit #7174, remain unchanged.
Western Blotting
Figure 1: Treatment of HeLa cells with TNF-alpha stimulates phosphorylation of NF-KappaB p65 at Ser536, detected by PathScanTM Phospho-NF-KappaB p65 (Ser536) Sandwich ELISA kit #7173, but does not affect the level of total NF-KappaB p65 detected by PathScanTM Total NF-KappaB p65 Sandwich ELISA kit #7174. OD 450 readings are shown in the top figure, while the corresponding Western blot using Phospho-NF-KappaB p65 (Ser536) (93H1) Rabbit mAb #3033 (right panel) or NF-KappaB p65 Antibody #3034 (left panel), is shown in the bottom figure.
Sandwich ELISA
Figure 2: The relationship between protein concentration of lysates from untreated and TNF-alpha-treated HeLa cells and kit assay optical density readings. After starvation, HeLa cells (85% confluence) were treated with TNF-alpha (10 ng/ml) for 7 min at 37oC, and then lysed.
Background
Transcription factors of the nuclear factor kappaB (NF-κB)/Rel family play a pivotal role in inflammatory and immune responses (1,2). There are five family members in mammals: RelA, c-Rel, RelB, NF-κB1 (p105/p50) and NF-κB2 (p100/p52). Both p105 and p100 are proteolytically processed by the proteasome to produce p50 and p52, respectively. Rel proteins bind p50 and p52 to form dimeric complexes that bind DNA and regulate transcription. In unstimulated cells, NF-κB is sequestered in the cytoplasm by IκB inhibitory proteins (3-5). NF-κB-activating agents can induce the phosphorylation of IκB proteins, targeting them for rapid degradation through an ubiquitin-proteasome pathway and releasing NF-κB to enter the nucleus where it regulates gene expression (6-8). NIK and IKK-α (IKK1) regulate the phosphorylation and processing of NF-κB2 (p100) to produce p52, which is then translocated to the nucleus (9-11).
- Baeuerle, P.A. and Henkel, T. (1994) Annu Rev Immunol 12, 141-79.
- Baeuerle, P.A. and Baltimore, D. (1996) Cell 87, 13-20.
- Haskill, S. et al. (1991) Cell 65, 1281-9.
- Thompson, J.E. et al. (1995) Cell 80, 573-82.
- Whiteside, S.T. et al. (1997) EMBO J 16, 1413-26.
- Traenckner, E.B. et al. (1995) EMBO J 14, 2876-83.
- Scherer, D.C. et al. (1995) Proc Natl Acad Sci USA 92, 11259-63.
- Chen, Z.J. et al. (1996) Cell 84, 853-62.
- Senftleben, U. et al. (2001) Science 293, 1495-9.
- Coope, H.J. et al. (2002) EMBO J 21, 5375-85.
- Xiao, G. et al. (2001) Mol Cell 7, 401-9.
- Peiser, M. et al. (2008) J Leukoc Biol , .
Application References
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
